VerifiedBiotechnology Research· Founded 2014

Cue Biopharma

Cue Biopharma, a clinical-stage biopharmaceutical company is developing a novel class of therapeutic biologics to selectively engage and modulate disease-relevant T cells for the treatment of autoimmune disease. Cue Biopharma’s proprietary platform, Immuno-STAT® (Selective Targeting and Alteration of T Cells) and biologics are designed to harness the curative potential of the body’s innate immune system through the selective modulation of disease-relevant T cells without the adverse effects of broad systemic immune activation.

7-day free trial · no credit card

Boston, United States38(11 to 50)$1M to <$10M2014cuebiopharma.com LinkedIn

Verified contacts

33

available on Kipplo

LinkedIn employees

38

11 to 50 range

Open roles

—

no listings

Distinct roles

23

indexed titles

Tech stack

0

tools in use

Monthly traffic

1.4K

organic / mo

Sign up free to see all 33 verified contacts at Cue Biopharma

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

33 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 33 verified contacts

Top roles at Cue Biopharma

23 distinct titles indexed · top 10 shown.

3scientist
3senior associate scientist
2principal scientist
1,,
1-'
1assistant controller
1associate director
1associate director toxicology & pharmacology
1associate director, translational pharmacology
1chief financial officer
+13more titles

Sign up to unlock all 33 contacts at Cue Biopharma

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 33 verified contacts at Cue Biopharma

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Cue Biopharma | Kipplo Discover